| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10916823 | Pathology - Research and Practice | 2016 | 9 Pages |
Abstract
Our study supports the important role of p53 and Ki67 expression in PDAC. They provide prognostic information in patients with adjuvant gemcitabine treatment and may contribute to treatment decision. However, these results should be validated in further studies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jana K. Striefler, Marianne Sinn, Uwe Pelzer, Anja Jühling, Lilianna Wislocka, Marcus Bahra, Bruno V. Sinn, Carsten Denkert, Bernd Dörken, Helmut Oettle, Hanno Riess, Hendrik Bläker, Philipp Lohneis,